Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bevacizumab (Phase 2)
Breast Neoplasms (Phase 2)
Bronchial Neoplasms (Phase 2)
Carcinoma, Bronchogenic (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Drugs, Investigational (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Immunotherapy (Phase 2)
Lung Diseases (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Neoplasms by Site (Phase 2)
Ovarian Diseases (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Early Phase 1)
Respiratory Tract Diseases (Phase 2)
Respiratory Tract Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Thoracic Neoplasms (Phase 2)
Thyroid Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue